EVENTIDE ASSET MANAGEMENT LLC 13D/13G Filings for Marinus Pharmaceuticals, Inc. (MRNS)

EVENTIDE ASSET MANAGEMENT LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
12:24 pm
Sale
2024-09-3013GMarinus Pharmaceuticals, Inc.
MRNS
EVENTIDE ASSET MANAGEMENT LLC0
0.000%
-4,529,997decrease
(Position Closed)
Filing
2024-02-14
12:18 pm
Purchase
2023-12-3113GMarinus Pharmaceuticals, Inc.
MRNS
EVENTIDE ASSET MANAGEMENT LLC4,529,997
8.300%
1,379,997increase
(+43.81%)
Filing
2023-02-14
1:32 pm
Purchase
2022-12-3113GMarinus Pharmaceuticals, Inc.
MRNS
EVENTIDE ASSET MANAGEMENT LLC3,150,000
6.600%
3,150,000increase
(New Position)
Filing